FEMSA's CEO expressed satisfaction with strong Q4 results, robust revenue growth across units, and Coca-Cola FEMSA's performance. He also discussed the impact of increased labor costs and the strategic plan to reach leverage objectives.
FEMSA's CEO highlighted robust performance, expressed confidence in organic growth especially in Proximity Americas and Coca-Cola FEMSA. Despite stability, expects solid growth in Health revenues and significant core business investment.
フォメント・エコノミコ・メヒカノに関するコメント
コラムTop upgrades and downgrades on 6/1
• $ブループリント・メディスン(BPMC.US)$ : Jefferies Upgrades to Buy from Hold - PT $78 (from $88)
• $CatchMark Timber Trust Inc(CTT.US)$ : Raymond James Upgrades to Market Perform from Underperform
• $ダナハー(DHR.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $310 (from $299)
• $エナンタ・ファーマシューティカルズ(ENTA.US)$ : Evercore ISI Upgrades to In Line from Underperform - PT $39 (from $35)
• $フォメント・エコノミコ・メヒカノ(FMX.US)$ : Bradesco BBI Upgrades to Outperform f...
コラムTop upgrades and downgrades on 5/5
• $アメリカン・キャピタル・エージェンシー(AGNC.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $13 (from $13.50)
• $エスペリオン・セラピューティクス(ESPR.US)$ : JP Morgan Upgrades to Neutral From Underweight
• $フォーティネット(FTNT.US)$ : Mizuho Securities Upgrades to Buy from Neutral - PT $350 (from $340)
• $Horizon Technology Finance(HRZN.US)$ : Compass Point Upgrades to Neutral From Sell
• $Momentive Global(MNTV.US)$ : Craig-Hallum Upgrades to Buy from Hold - PT $...
コラムTop upgrades and downgrades on 2/1
Tuesday, February 1, 2022
$ウェルズ・ファーゴ(WFC.US)$$モデルナ(MRNA.US)$$バイオエヌテック(BNTX.US)$$エンタープライズ・プロダクツ・パートナーズ(EPD.US)$$フォメント・エコノミコ・メヒカノ(FMX.US)$$インテュイット(INTU.US)$$シスコ(SYY.US)$$Healthpeak Properties(PEAK.US)$
まだコメントはありません